Historique
Bulletin de Périodique
European Addiction Research , Vol.28, n°5 - September 2022
Paru le :
01/09/2022
Article en page(s) :
323-400
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- New synthetic opioids use among patients in treatment for an opioid use disorder in Barcelona. Alias-Ferri M., Marchei E., Pacifici R., Pichini S., Pellegrini M., Perez-Mana C., et al., p. 323-330.
- Identifying subgroups of cannabis users based on help-seeking preferences: A latent class analysis. Olthof M.I.A., Blankers M., van Laar M.W., Goudriaan A.E., p. 331-339.
- The effects of oxytocin on craving, mental health parameters, and stress hormones in methamphetamine-dependent patients undergoing matrix treatment model: A randomized, double-blind clinical trial. Azadbakht A., Salehi M., Maracy M.R., Banafshe H.R., p. 340-349.
- Cognitive impairments in patients with GHB use disorder predict relapse in GHB use. Beurmanjer H., Bruijnen C., Greeven P.G.J., De Jong C.A.J., Schellekens A.F.A., Dijkstra B.A.G., p. 350-357.
- Mortality, causes of death, and predictors of death among patients on and off opioid agonist treatment: Results from a 19-year cohort study. Skeie I., Clausen T., Hjemsæter A.J., Landheim A.S., Monsbakken B., Thoresen M., et al., p. 358-367.
- Substance use, substance use disorders, and co-occurring psychiatric disorders in recently incarcerated men: A comparison with the general population. Fovet T., Wathelet M., Benbouriche M., Benradia I., Roelandt J.L., Thomas P., et al., p. 368-376.
- Cognitive functioning in long-term benzodiazepine users. Zetsen S.P.G., Schellekens A.F.A., Paling E.P., Kan C.C., Kessels R.P.C., p. 377-381.
- S3 Guideline "Smoking and tobacco dependence: Screening, diagnosis, and treatment" - Short version. Batra A., Kiefer F., Andreas S., Gohlke H., Klein M., Kotz D., et al., p. 382-400.
- New synthetic opioids use among patients in treatment for an opioid use disorder in Barcelona. Alias-Ferri M., Marchei E., Pacifici R., Pichini S., Pellegrini M., Perez-Mana C., et al., p. 323-330.
- Identifying subgroups of cannabis users based on help-seeking preferences: A latent class analysis. Olthof M.I.A., Blankers M., van Laar M.W., Goudriaan A.E., p. 331-339.
- The effects of oxytocin on craving, mental health parameters, and stress hormones in methamphetamine-dependent patients undergoing matrix treatment model: A randomized, double-blind clinical trial. Azadbakht A., Salehi M., Maracy M.R., Banafshe H.R., p. 340-349.
- Cognitive impairments in patients with GHB use disorder predict relapse in GHB use. Beurmanjer H., Bruijnen C., Greeven P.G.J., De Jong C.A.J., Schellekens A.F.A., Dijkstra B.A.G., p. 350-357.
- Mortality, causes of death, and predictors of death among patients on and off opioid agonist treatment: Results from a 19-year cohort study. Skeie I., Clausen T., Hjemsæter A.J., Landheim A.S., Monsbakken B., Thoresen M., et al., p. 358-367.
- Substance use, substance use disorders, and co-occurring psychiatric disorders in recently incarcerated men: A comparison with the general population. Fovet T., Wathelet M., Benbouriche M., Benradia I., Roelandt J.L., Thomas P., et al., p. 368-376.
- Cognitive functioning in long-term benzodiazepine users. Zetsen S.P.G., Schellekens A.F.A., Paling E.P., Kan C.C., Kessels R.P.C., p. 377-381.
- S3 Guideline "Smoking and tobacco dependence: Screening, diagnosis, and treatment" - Short version. Batra A., Kiefer F., Andreas S., Gohlke H., Klein M., Kotz D., et al., p. 382-400.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
M. ALIAS-FERRI ;
E. MARCHEI ;
R. PACIFICI ;
S. PICHINI ;
M. PELLEGRINI ;
C. PEREZ-MANA ;
E. PAPASEIT ;
R. MUGA ;
F. FONSECA ;
M. FARRE ;
M. TORRENS
|
2022
Dans European Addiction Research (Vol.28, n°5, September 2022) Article : Périodique
Dans European Addiction Research (Vol.28, n°5, September 2022) Article : Périodique
INTRODUCTION: New synthetic opioids (NSO), a class of new psychoactive substances (NPS), have recently emerged and pose an upcoming global public health challenge. The effects produced by NSO are similar to those from morphine, but they present [...]
T. FOVET ;
M. WATHELET ;
M. BENBOURICHE ;
I. BENRADIA ;
J. L. ROELANDT ;
P. THOMAS ;
F. D'HONDT ;
B. ROLLAND
|
2022
Dans European Addiction Research (Vol.28, n°5, September 2022) Article : Périodique
Dans European Addiction Research (Vol.28, n°5, September 2022) Article : Périodique
INTRODUCTION: The rates of alcohol and illegal drug use and the prevalence of alcohol and illegal drug use disorders (AUDs and DUDs) are high in prison populations, particularly in men entering jail. However, these rates have never been exhausti[...]
A. BATRA ;
F. KIEFER ;
S. ANDREAS ;
H. GOHLKE ;
M. KLEIN ;
D. KOTZ ;
U. MONS ;
S. MUHLIG ;
M. POTSCHKE-LANGER ;
U. W. PREUSS ;
T. RUTHER ;
C. RUSTLER ;
R. THOMASIUS ;
S. ULBRICHT ;
K. U. PETERSEN
|
2022
Dans European Addiction Research (Vol.28, n°5, September 2022) Article : Périodique
Dans European Addiction Research (Vol.28, n°5, September 2022) Article : Périodique
INTRODUCTION: In addition to the prevention of tobacco consumption, the establishment and assurance of high-quality treatment for harmful use and dependence on tobacco products remains an important health-related task in Germany. Regular updatin[...]